|
Announcements
PROMEGA CORPORATION
SELECTS CLINIVATION'S GLOBAL MARKET CLEARANCE SERVICES Global
leader in providing innovative solutions and technical support to the life sciences
industry selects clinivation's Global Market Clearance Services to position their
operations for continued growth and successful expansion Natick,
MA, March 5, 2009 - clinivation, Inc. announced today that Promega Corporation
has selected clinivation's Global Market Clearance Services.
"Promega
is a world leader in the development and manufacture of DNA, RNA, protein, and
cell-analysis kits, as well as Integrated Solutions for the life science industry.
We are pleased that they have selected clinivation's Global Market Clearance Services
to position their operations for continued growth and successful expansion," said
Richard Morroney, R.A.C., C.Q.A., clinivation's Vice President, Global Market
Clearance Solutions. About clinivation's Global Market
Clearance Services Clinivation's Global Market Clearance
services leverage our excellence in market clearance and many years of focused,
successful experience in developing and supporting thousands of medtech market
clearance applications in all of the major and emerging world markets. Our many
years of successful experience spans from comprehensive initiation, support, and
execution of the most complex Class III PMA programs to focused global market
clearance initiatives. About Promega Corporation
Promega Corporation is a leader in providing innovative solutions and technical
support to the life sciences industry. The company's 2,000 products enable scientists
worldwide to advance their knowledge in genomics, proteomics, cellular analysis,
molecular diagnostics, and human identification. Founded in 1978, the company
is headquartered in Madison, WI, USA with branches in 14 countries and over 50
global distributors. For more information, please visit www.promega.com.
About clinivation, Inc. Clinivation
is the leading provider of integrated solutions that enable global market clearance.
Guided by our singular vision - "Excellence in Market Clearance" - clinivation
accelerates the entire market clearance cycle to advance new worldwide revenue
and achieve new milestones of enterprise value. Used in over 1,000,000 product
registrations by more than 100 companies worldwide, clinivation's end-to-end technology
and services deliver on our vision by eliminating revenue traps from global market
clearance operations, increasing process velocity with on-demand regulatory intelligence,
automating clearance-driven business controls, simplifying content unification
into market clearance applications, aligning quality systems with global market
clearance priorities, streamlining clinical development with clearance-focused
trials, and enabling management with key performance indicators for continuous
improvement and effective governance. The world's leading medical device,
diagnostics, hospital supply, and dental supply companies select clinivation because
of our medtech industry focus and our unique, integrated solutions that seamlessly
adapt to existing business processes and enterprise infrastructure- without the
need to write custom code. Our core brands include the clinivation Global®
xi market clearance platform, clinivation WorldView® on-demand
regulatory intelligence, and clinivation Clinical Suite® and clinivation
Registry Suite® electronic data capture and clinical data management
software. Founded in 1999, the company is headquartered in Natick, Massachusetts,
with regional offices in North America and Asia. Visit clinivation online
at www.clinivation.com For
further information: For more information on clinivation's
integrated solutions that enable global market clearance, please click
here or call us at 508.655.6560. | 
